Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Arrhythmia Clinical Trials

A listing of Arrhythmia medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (140) clinical trials

Sponsor has developed a leadless cardiac pacemaker (LCP) system to eliminate leads, pockets, and connectors required by conventional pacemakers and to eliminate associated complications. This concept could improve patient comfort by replacing a surgical procedure with a percutaneous one, eliminating the visible lump and scar at a conventional pacemaker’s pectoral ...

Phase N/A

Prospective, single arm, open-label, multicenter, post-market interventional clinical study to determine, via continuous monitoring with the Reveal XT implantable cardiac monitor (ICM), the incidence of atrial fibrillation (AF) in patients suspected to be at high risk for having AF and to understand how physicians manage these patients once AF has ...

Phase N/A

The primary objective is to understand the role of ATP in primary prevention patients indicated for ICD therapy. The incidence of all-cause shocks in subjects programmed with shocks only will be compared with subjects programmed to standard therapy (ATP and shock) to assess equivalency. Multivariate analyses will also be performed to ...

Phase N/A

This research study is investigating a medical device called the ZOLL Short-term use Wearable Defibrillator (“SWD 1000”).  A defibrillator is a device used to control an abnormal heart beat by applying an electric current, also known as "shocking", to the chest wall or heart. We are asking you to take ...

Phase N/A

Enhanced Diagnosis of Ventricular Activation Pattern Using Intracardiac Electrograms

The objective of this study will be to evaluate the ability of IEGMs (Signal recorded from implanted pacing leads) and pseudo ECGs (derived from various IEGMs) to characterize various electrical conduction patterns. Electroanatomic mapping data and 12 Lead ECG will also be collected to characterize electrical conduction patterns during standard ...

Phase

Clinical and Device Functional Assessment of Real World ICD Patients

For these reasons, it is very important to observe the clinical practice on a large variety of centers and countries, with the objective to collect long term safety and performance data in patients undergoing ICD/CRT-D device implantation (first implant, replacement or upgrade). The safety and performance of the ICDs can ...

Phase N/A

Evaluation of PET/MR in Patients Selected for Ablation Therapy

This study is performed to assess if PET-MR imaging can improve treatment of patients with irregular heart rate and heart failure. Heart failure occurs when the heart muscle is too weak to do his work correctly. Irregular heart rate can be related to numerous diseases. One category of irregular heart ...

Phase

Risk Assessment in Patients With Symptomatic- and Asymptomatic Preexcitation

Hypothesis The sensitivity and specificity for exercise stress test (bicycle) is low in identifying patients with benign accessory pathways and cannot replace an invasive electrophysiological study in risk assessment of symptomatic and asymptomatic patients with pre-excitation. Invasive electrophysiological assessment should be recommended for all patients with pre-excitation despite symptoms or ...

Phase N/A

Esmolol to Treat the Hemodynamic Effects of Septic Shock

Septic shock is a leading cause of death around the world, with a mortality that often ranges 30-50% but in some locations may be even higher. Despite advances in critical care medicine over the last several decades, few therapeutic interventions have demonstrated mortality benefit in this population besides antimicrobial medications, ...

Phase

EASYER (EpiAccess SYstem Registry) A Post Market Observational Registry

The Registry will be a prospective non-randomized single-arm trial of up to 150 patients enrolled in up to ten (10) centers in the United States. The overall duration of the registry is estimated to be 18 months per site. For the patients the registry duration will be from the time ...

Phase N/A